Differential transcriptome and development of human peripheral plasma cell subsets
Authors:
- Swetha GarimallaSGSwetha Garimalla
- Doan C. NguyenDNDoan C. Nguyen
- Jessica L. HallileyJHJessica L. Halliley
- Christopher TiptonCTChristopher Tipton
- Alexander F. RosenbergARAlexander F. Rosenberg
- Christopher F. FucileCFChristopher F. Fucile
- Celia L. SaneyCSCelia L. Saney
- Shuya KyuSKShuya Kyu
- Denise KaminskiDKDenise Kaminski
- Yu QianYQYu Qian
- Richard H. ScheuermannRSRichard H. Scheuermann
- Greg GibsonGreg Gibson
- 2 May 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (9)
Abstract
Human antibody-secreting cells (ASCs) triggered by immunization are globally recognized as CD19 lo CD38 hi CD27 hi . Yet, different vaccines give rise to antibody responses of different longevity, suggesting ASC populations are heterogeneous. We define circulating-ASC heterogeneity in vaccine responses using multicolor flow cytometry, morphology, V H repertoire, and RNA transcriptome analysis. We also tested differential survival using a human cell-free system that mimics the bone marrow (BM) microniche. In peripheral blood, we identified 3 CD19 + and 2 CD19 – ASC subsets. All subsets contributed to the vaccine-specific responses and were characterized by in vivo proliferation and activation. The V H repertoire demonstrated strong oligoclonality with extensive interconnectivity among the 5 subsets and switched memory B cells. Transcriptome analysis showed separation of CD19 + and CD19 – subsets that included pathways such as cell cycle, hypoxia, TNF-α, and unfolded protein response. They also demonstrated similar long-term in vitro survival after 48 days. In summary, vaccine-induced ASCs with different surface markers (CD19 and CD138) are derived from shared proliferative precursors yet express distinctive transcriptomes. Equal survival indicates that all ASC compartments are endowed with long-lived potential. Accordingly, in vivo survival of peripheral long-lived plasma cells may be determined in part by their homing and residence in the BM microniche.Keywords
Funding Information
- NIH/NIAID, NIH/NCATS (NIH: NIAID: R01AI121252,K23 AI67501,P01AI125180,U19AI1109962,5 P01 A1078907-04,R37AI049660,U01AI045969,Autoimmunity Center of Excellence- ARRA:AI056390-06S2,HHSN266200500030C (N01-AI50029),AI078907,AI049600,NIH/NCATS UL1 TR000454)
This publication has 61 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cellsJournal of Experimental Medicine, 2011
- Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunizationVaccine, 2010
- Supervised normalization of microarraysBioinformatics, 2010
- IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responsesJournal of Experimental Medicine, 2010
- Elucidation of seventeen human peripheral blood B‐cell subsets and quantification of the tetanus response using a density‐based method for the automated identification of cell populations in multidimensional flow cytometry dataCytometry Part B: Clinical Cytometry, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myelomaOncogene, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005